130 results
424B3
CYCC
Cyclacel Pharmaceuticals Inc
14 Feb 24
Prospectus supplement
4:06pm
are not sustainable and are highly volatile.
Whether or not meritorious, litigation brought against us could result in substantial costs, divert our
424B4
mvjztuxhqlsdm9en
21 Jul 17
Prospectus supplement with pricing info
12:00am
424B5
uh33u33y
4 Mar 15
Prospectus supplement for primary offering
12:00am
424B5
nhh7sahh
3 Mar 15
Prospectus supplement for primary offering
12:00am